155 related articles for article (PubMed ID: 25095906)
1. Multiple complexes of long aliphatic N-acyltransferases lead to synthesis of 2,6-diacylated/2-acyl-substituted glycopeptide antibiotics, effectively killing vancomycin-resistant enterococcus.
Lyu SY; Liu YC; Chang CY; Huang CJ; Chiu YH; Huang CM; Hsu NS; Lin KH; Wu CJ; Tsai MD; Li TL
J Am Chem Soc; 2014 Aug; 136(31):10989-95. PubMed ID: 25095906
[TBL] [Abstract][Full Text] [Related]
2. Teicoplanin Reprogrammed with the N-Acyl-Glucosamine Pharmacophore at the Penultimate Residue of Aglycone Acquires Broad-Spectrum Antimicrobial Activities Effectively Killing Gram-Positive and -Negative Pathogens.
Huang CM; Lyu SY; Lin KH; Chen CL; Chen MH; Shih HW; Hsu NS; Lo IW; Wang YL; Li YS; Wu CJ; Li TL
ACS Infect Dis; 2019 Mar; 5(3):430-442. PubMed ID: 30599088
[TBL] [Abstract][Full Text] [Related]
3. Tailoring of glycopeptide scaffolds by the acyltransferases from the teicoplanin and A-40,926 biosynthetic operons.
Kruger RG; Lu W; Oberthür M; Tao J; Kahne D; Walsh CT
Chem Biol; 2005 Jan; 12(1):131-40. PubMed ID: 15664522
[TBL] [Abstract][Full Text] [Related]
4. Glycopeptide antibiotics: from conventional molecules to new derivatives.
Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM
Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
[TBL] [Abstract][Full Text] [Related]
5. Regioselective deacetylation based on teicoplanin-complexed Orf2* crystal structures.
Chan HC; Huang YT; Lyu SY; Huang CJ; Li YS; Liu YC; Chou CC; Tsai MD; Li TL
Mol Biosyst; 2011 Apr; 7(4):1224-31. PubMed ID: 21267472
[TBL] [Abstract][Full Text] [Related]
6. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides.
Maffioli SI; Ciabatti R; Romanò G; Marzorati E; Preobrazhenskaya M; Pavlov A
Bioorg Med Chem Lett; 2005 Aug; 15(16):3801-5. PubMed ID: 15993054
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the synthesis of new glycopeptide antibiotics.
Ashford PA; Bew SP
Chem Soc Rev; 2012 Feb; 41(3):957-78. PubMed ID: 21829829
[TBL] [Abstract][Full Text] [Related]
11. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
[TBL] [Abstract][Full Text] [Related]
12. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
Scheinfeld N
J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
[TBL] [Abstract][Full Text] [Related]
13. [Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].
Olsuf'eva EN; Preobrazhenskaia MN
Bioorg Khim; 2006; 32(4):339-59. PubMed ID: 16909859
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activities of novel tyrocidine A glycosylated derivatives towards multidrug-resistant pathogens.
Zou Y; Zhao Q; Zhang C; Wang L; Li W; Li X; Wu Q; Hu H
J Pept Sci; 2015 Jul; 21(7):586-92. PubMed ID: 25900908
[TBL] [Abstract][Full Text] [Related]
15. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.
Treviño J; Bayón C; Ardá A; Marinelli F; Gandolfi R; Molinari F; Jimenez-Barbero J; Hernáiz MJ
Chemistry; 2014 Jun; 20(24):7363-72. PubMed ID: 24805824
[TBL] [Abstract][Full Text] [Related]
16. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant
Koteva K; Xu M; Wang W; Fiebig-Comyn AA; Cook MA; Coombes BK; Wright GD
J Med Chem; 2023 Jul; 66(13):9006-9022. PubMed ID: 37315221
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptide antibiotics and their novel semi-synthetic derivatives.
Jeya M; Moon HJ; Lee KM; Kim IW; Lee JK
Curr Pharm Biotechnol; 2011 Aug; 12(8):1194-204. PubMed ID: 21470154
[TBL] [Abstract][Full Text] [Related]
19. Oritavancin - a new semisynthetic lipoglycopeptide agent to tackle the challenge of resistant gram positive pathogens.
Das B; Sarkar C; Schachter J
Pak J Pharm Sci; 2013 Sep; 26(5):1045-55. PubMed ID: 24035967
[TBL] [Abstract][Full Text] [Related]
20. Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance.
Zeng D; Debabov D; Hartsell TL; Cano RJ; Adams S; Schuyler JA; McMillan R; Pace JL
Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27663982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
